| Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study L Le Clech, JP Talarmin, MA Couturier, JC Ianotto, C Nicol, R Le Calloch, ... Infectious Diseases 50 (7), 539-549, 2018 | 72 | 2018 |
| Hemorrhage in essential thrombocythemia or polycythemia vera: epidemiology, location, risk factors, and lessons learned from the literature C Nicol, K Lacut, B Pan-Petesch, E Lippert, JC Ianotto Thrombosis and Haemostasis 121 (05), 553-564, 2021 | 25 | 2021 |
| Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations C Nicol, B Pan‐Petesch, JC Ianotto Haemophilia 28 (6), 938-949, 2022 | 5 | 2022 |
| Acquired von Willebrand syndrome and lymphoproliferative disorders: a case report C Nicol, L Raj, G Guillerm, F Couturaud, JR Eveillard, B Pan‐Petesch Clinical Case Reports 8 (5), 900-904, 2020 | 5 | 2020 |
| Hemorrhages in Polycythemia Vera and Essential Thrombocythemia: Epidemiology, Description, and Risk Factors—Learnings from a Large Cohort C Nicol, N Ajzenberg, K Lacut, F Couturaud, E Lippert, B Pan-Petesch, ... Thrombosis and Haemostasis 122 (10), 1712-1722, 2022 | 1 | 2022 |
| CKS1B/CDKN2C Copy Number Ratio: A New Predictor of Survival in Transplant-and Non Transplant-Eligible Multiple Myeloma Patients S Dos Santos, L Herbreteau, C Nicol, V Rebière, H Galinat, JC Ianotto, ... Blood 132, 2017, 2018 | 1 | 2018 |
| Biosimilars of filgrastim in autologous stem cell transplantation: certain differences for myeloma patients only C Nicol, C Henry, MA Couturier, P Delépine, C Tripogney, C Buors, ... Leukemia & lymphoma 58 (9), 2258-2260, 2017 | 1 | 2017 |
| CALR‐mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM L Aubin, R Vilas Boas, R Daltro De Oliveira, V Le Brun, M Divoux, J Rey, ... American Journal of Hematology, 2024 | | 2024 |
| CDKN2C Deletion on 1p32 Locus As Part of Irwazh Score, a New Risk Assessment Model for Venous Thromboembolism Occurring within 6-12 Months of Treatment Initiation in Newly … JR Eveillard, N Douet-Guilbert, A Basinko, R Kerdoncuff, A Tempescul, ... Blood 142, 4735, 2023 | | 2023 |
| Néoplasies myéloprolifératives et hémopathies lymphoïdes: une association rare mais une même origine clonale? C Nicol, JC Ianotto Hématologie 26 (6), 290-292, 2020 | | 2020 |
| PF680 MAJOR OR CLINICALLY RELEVANT NON-MAJOR HEMORRHAGIC EVENTS IN A LARGE POPULATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA: LOCALIZATION … C Nicol, B Pan-Petesch, C Leostic, G Guillerm, L Herbreteau, K Lacut, ... HemaSphere 3 (S1), 294, 2019 | | 2019 |
| Prise en charge de la polyglobulie de Vaquez en Europe centrale: des recommandations osées? C Nicol, JC Ianotto Hématologie 24 (6), 346-347, 2018 | | 2018 |
| BIOSIMILARS OF FILGRASTIM HAVE AN EQUIVALENT EFFICACY WHEN USED AFTER PERIPHERAL BLOOD STEM CELL TRANSPLANTATION C Nicol, C Henry, P Delepine, C Tripogney, C Buors, G Guillerm, ... HAEMATOLOGICA 101, 855-855, 2016 | | 2016 |
| Hémopathies diverses et méthodes d’études L Le Clech, MA Couturier, JC Ianotto, C Nicol, R Le Calloch, ... Hématologie 22, 1, 2016 | | 2016 |
